Sorafenib- Taurine Combination Model for Hepatocellular Carcinoma Cells: Immunological Aspects.
This study could open new avenues for the improvement of therapeutic efficacy of Sorafenib treated HCC patients by using Tau in combination.
PMID: 31653148 [PubMed - in process]
Source: Asian Pacific Journal of Cancer Prevention - Category: Cancer & Oncology Tags: Asian Pac J Cancer Prev Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Genetics | Hepatocellular Carcinoma | Liver Cancer | Study